PFIZER.NS Profit & Loss

Pfizer Ltd.

Profit & Loss · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-23 23:42

Line item	FY2022-23 standalone basis	FY2023-24 standalone basis	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹24.25 Bn	₹21.93 Bn	₹22.81 Bn	₹25.20 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹1.01 Bn	₹1.81 Bn	₹1.72 Bn	₹1.88 Bn	OtherIncome
Total Income	₹25.26 Bn	₹23.74 Bn	₹24.54 Bn	₹27.08 Bn	Income
Cost of Materials Consumed	₹3.45 Bn	₹3.36 Bn	₹2.72 Bn	₹3.10 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹4.72 Bn	₹4.69 Bn	₹5.13 Bn	₹6.08 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹0.56 Bn	₹-0.12 Bn	₹0.25 Bn	₹-0.34 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹3.32 Bn	₹3.48 Bn	₹3.71 Bn	₹3.68 Bn	EmployeeBenefitExpense
Finance Costs	₹0.13 Bn	₹0.15 Bn	₹0.08 Bn	₹0.09 Bn	FinanceCosts
Depreciation and Amortisation	₹1.06 Bn	₹0.62 Bn	₹0.61 Bn	₹0.58 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹4.11 Bn	₹4.17 Bn	₹3.59 Bn	₹3.63 Bn	OtherExpenses
Total Expenses	₹17.35 Bn	₹16.36 Bn	₹16.10 Bn	₹16.83 Bn	Expenses
Profit Before Exceptional Items and Tax	₹7.91 Bn	₹7.38 Bn	₹8.43 Bn	₹10.25 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹0.33 Bn	₹0.08 Bn	₹1.73 Bn	₹-0.49 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹8.24 Bn	₹7.46 Bn	₹10.16 Bn	₹9.76 Bn	ProfitBeforeTax
Tax Expense	₹2.00 Bn	₹1.95 Bn	₹2.48 Bn	₹2.53 Bn	TaxExpense
Net Profit (incl. minority interest)	₹6.24 Bn	₹5.51 Bn	₹7.68 Bn	₹7.22 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	N/A	N/A	N/A	N/A	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹136.38	₹120.51	₹167.79	₹157.92	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹136.38	₹120.51	₹167.79	₹157.92	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from PFIZER.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).